DGE invites leaders, executives and professionals from the biotech, pharma, and medical device sectors, to attend the 5th Clinical Trials Agreements Conference being held August 21-22, 2024, in Philadelphia. The conference focuses on discussions such as accelerating negotiations, AI advancements, fair market value, and building a modern day clinical site budget.
The event is hosted by Dynamic Global Events (“DGE”), a global leader in organizing B2B events. The global event company caters to the dynamic informational and networking needs of the pharma, biotech, medical devices, and all healthcare industries.
Clinical Trial Agreements rely on effective communication among sponsors, CROs, and the research institution. Key topics that will be covered include enhancing communication transparency, evaluating the impact of CROs on negotiation timelines, and highlighting site forms and institution policies in CTAs.
Featured topics covered include:
- Apply Key Lessons from Decentralized and Remote Clinical Trials
- Evaluate the Impact of CROs on Negotiation Timelines
- Fast-Track Your CTA Negotiations: Key Factors and Best practices
- Examine the Recent FDA Guidance Surrounding Digital Health Technologies
- Revolutionize Contract Review Processes by Harnessing AI to Enhance Operational Efficiency
- Map out CTAs in a Global Landscape
- Build a Modern – Day Clinical Site Budget: Hybrid Studies, DCT, and Naïve Sites
In addition, attendees can learn the intricacies of CTA negotiations from industry experts through audience Q&A as well as networking breaks. We hope to see you there!
To know more, please visit https://ibn.fm/Bjrxt.
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]
InvestorWire is powered by IBN